Gain valuable perspectives and resources to navigate the challenges of Triple Negative Breast Cancer through the eyes of a survivor.
The FDA approved a combination of immunotherapy and chemotherapy for patients with advanced triple-negative breast cancer. Here's what you need to know.
Looking for top surgical instrument companies in the world? We offer health staff recruitment services, medical equipment and healthcare assistant jobs with the NHS.
As breast cancer deaths decline in America, racial disparities persist in the mortality rates between Black and white women. Those rates remain 40 percent higher for Black women, who are also more likely than white women to be diagnosed with breast cancer under the age of 50 and to get the rare and aggressive triple-negative subtype…
Triple-negative breast cancer is an aggressive, fast-growing form of breast cancer. The 5-year relative survival rate for this cancer is 77%. Read more here.
Triple-negative breast cancer (TNBC) accounts for approximately 15% of all breast cancer and is often aggressive with worse outcomes compared with other breast cancer subtypes.
The vaccine targets triple negative breast cancers which make up about 10 to 15 percent of all breast cancers.
Triple-negative breast cancer accounts for about 10-20% of all cases. TNBC is a form of Breast cancer that tests negative...
People who received the antibody-drug conjugate were also more likely to experience tumor remission.
Trodelvy led to better disease control and improved quality of life compared to chemotherapy in patients with triple-negative breast cancer.
For high-risk patients with triple-negative breast cancer who have residual disease following neoadjuvant therapy, Dr Kathy Miller says we must accept capecitabine as the standard of care.
Katie Britton-Jordan, 38, was diagnosed with stage 2a triple negative breast cancer last year after discovering a lump as a result of breastfeeding
Triple-negative breast cancer (TNBC) is an aggressive cancer, more likely to be recurrent. Learn what it is, symptoms, treatment, prognosis and survival rates.
Katie Britton-Jordan, 38, was diagnosed with stage 2a triple negative breast cancer last year after discovering a lump as a result of breastfeeding
Scientific evidence supporting the involvement of the enzyme MAPK4 in cancer growth and resistance to certain therapies has been growing quickly. In a current study published in the journal Nature Communications, a team at Baylor College of Medicine and collaborating institutions reports that MAPK4 seems to play an important role in triple-negative breast cancer (TNBC), a devastating disease with limited therapeutic options.
Israel has been one of the leading countries in the development of breast cancer therapies and research. In honor of Breast Cancer Awareness month, here are 10 ways that Israel has been leading the fight against breast cancer.
In January, Nicola Tracey sat down with her two young daughters and tried to do the impossible - to find the right words to tell them she had only months left to live.
Beetroot RECOMMENDATION Beetroot is great roasted, cold in salads, picked as a side dish or juiced.If you are not eating organic beetroot, be sure to peel the beet before consumption as they do tend to contain some pesticides on the skin surface. Why Beetroot is good for us CONSUME MODERATELY Beetroot is an excellent source
After nearly a month of testing, on January 26, 2023, I learned that I have Invasive Ductal Carcinoma-Triple Negative Breast Cancer (TNBC), stage 2, grade 3. Insert the classic Lifetime movie time …
Welsh Radio 5 Live newsreader Rachael Bland, 40 (pictured) said: 'In the the words of Frank Sinatra, I'm afraid to say the time has come my friends. And suddenly I'm told I've only got days.'
Combinational Therapy in Triple Negative Breast Cancer discusses TNBC at the molecular level from a holistic approach, focusing on combinational strategies targeting various pathways involved in this specific cancer type. Using a monotherapy for the treatment of cancer, especially high-grade tumors like TNBC, is mostly worthless due to the inherent genetic instability of tumor cells to develop intrinsic and acquired resistance. Combination therapy presents more, or at least the same, effectiveness with lower doses of every single agent and decreases the likelihood of chemoresistance, making it essential to understand for multiple therapy options. The book is a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of combinational therapies to treat triple negative breast cancer.
Stephanie shares her stage 3 triple-negative breast cancer story, including chemotherapy, double mastectomy, and breast reconstruction.
With a young resident observing silently in the corner, the surgeon pulled out a clipboard...
For the first time, a survival benefit with immunotherapy has been shown in breast cancer with atezolizumab plus chemotherapy in triple negative patients.
Triple-negative inflammatory breast cancer survivor Terry Arnold waited 10 years after her double mastectomy to have reconstructive breast surgery. Her DIEP procedure was combined with a lymphedema bypass, bringing relief from a long-time side effect.
The Food and Drug Administration’s recent approval of the first antibody-drug conjugate to treat patients with pretreated metastatic triple-negative breast cancer is a major milestone, according to one expert.
Triple-negative breast cancer can be treated with medication, chemotherapy, radiation, and surgery. Explore these options and how they are used.
Learn about the treatment options for triple-negative breast cancer (TNBC).
Women magazine interviews Joan Lunden about her breast cancer.
Researchers have developed an artificial intelligence model that can predict if triple negative breast cancer will spread.
Researchers confirm the risk of triple negative breast cancer in obese women who are also physically inactive, and suggest additional mechanisms other than estrogen. …The Association Between…
There’s some real hope for the future.
What drives innovation? For Dr. Trey Westbrook it’s a personal mission to find new treatments for invasive breast cancer. His work focuses on the genetic
